Skip to main content

Table 4 Degree of dyspnea, state of health, exercise capacity, analytical determinations and radiological involvement at 12 months depending on the presence or absence of DLNO < LLN

From: Evolution and long‑term respiratory sequelae after severe COVID-19 pneumonia: nitric oxide diffusion measurement value

Variables

DLNO ≥ LLN

DLNO < LLN

P

Dyspnea according to mMRC

N = 151

N = 36

 

Dyspnea ≥ 1, N (%)

58 (38.4)

14 (41.7)

0.60

Dyspnea ≥ 2, N (%)

14 (9.3)

7 (20.4)

0.04

Dyspnea

0 (0–1)

0 (0–1)

0.42

Health status according to Nottingham Health Profile

N = 150

N = 33

 

Energy

0 (0–33.3)

0 (0–33.3)

0.15

Pain

12.5 (0–37.5)

12.5 (0–25)

0.33

Physical mobility

12 (0–37.5)

25 (0–37.5)

0.72

Emotional reactions

11.1 (0–33.3)

11.1 (0–33.3)

0.70

Sleep

20 (0–60)

20 (0–60)

0.52

Social isolation

0 (0–0)

0 (0–1)

0.46

Number of limited areas

3 (1–5)

3 (1–5)

0.95

Exercise capacity (6MWT)

N = 142

N = 34

 

Distance, m

519.5 (472.5–562.2)

487.5 (359.7–547.7)

0.02

Initial oxygen saturation, %

98 (97–98)

97 (96–98)

0.004

Final oxygen saturation, %

97 (96–98)

96 (94–97)

0.001

Initial Borg scale dyspnea (1–10)

0 (0–1)

0 (0–1)

0.16

Final Borg scale dyspnea (1–10)

2 (0–5)

2 (0–4)

0.40

Laboratory parameters

N = 151

N = 35

 

D-dimer, ng/mL

312 (215–458)

395 (253–738)

0.01

Lactate deshydrogenase, U/L

192 (173–211)

184 (173–203)

0.10

Chest X-ray

N = 151

N = 37

 

Persistence of any lung injuries, N (%)

9 (6)

2 (5.6)

0.9

Chest CT

N = 44

N = 22

 

Score extension affectation

5.5 (2–8.7)

4 (3–8.2)

0.84

Ground glass opacities > 25%, N (%)

8 (18.2)

4 (18.2)

0.90

Presence of reticulation, N (%)

10 (22.7)

10 (45.4)

0.05

Presence of bronchiectasis, N (%)

13 (29.5)

7 (31.8)

0.95

  1. Median (25th and 75th percentile). Mann–Whitney test
  2. DLNO diffusion capacity of nitric oxide, LLN lower limits of normal, mMRC Modified Medical Research Council, 6MWT six-minute walk test, CT computerized tomography